Sep 2026 · Announcement under Regulation 30 (LODR)-Allotment 3 Sep - Finance committee approved 550 crore private placement NCDs on 3 September 2026.
Source: Bse
Auto stocks · Large cap · NSE
Balkrishna Industries Ltd. (BKT) is an Indian manufacturer of Off-Highway Tyres (OHT) for agriculture, construction, mining, and industrial applications, with a global presence. It also produces carbon black and recently entered the On-Highway (CV Radial, PCR) tyre segment in India, targeting the replacement market.
full bear SMA stack · SMA20 -8.1% / mo · MACD + · near 52W low · sector -2.2pp vs Nifty 500 (3M)
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is weak.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +25.2% · PAT +56.6% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev +25% YoY · PAT +57% YoY · margin expansion · +18% QoQ · operating leverage
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹3,455 Cr | +25.2% | +17.8% |
| EBITDA | ₹744 Cr | +47.0% | +16.3% |
| Operating margin | 22.0% | +400 bps | +0 bps |
| PAT | ₹451 Cr | +56.6% | +50.8% |
| PAT margin | 13.1% | +262 bps | +286 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 21/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Signals are conflicting — long-term trend down. RSI 40. Wait for confirmation.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 30 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
Consumer franchises can deserve higher multiples, but only when growth quality supports them.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in Auto — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
FY26 revenue flat YoY at Rs. 10,656 Cr, with OHT volumes up 1%. EBITDA declined 10% YoY to Rs. 2,423 Cr, and Net Profit fell 25% YoY to Rs. 1,222 Cr, indicating significant margin pressure. Q4FY26 showed slight revenue and volume growth but continued profit decline.
Management is aggressively expanding into new segments (On-Highway, advanced Carbon Black) and capacities, targeting significant revenue growth by FY30. However, FY26 saw notable margin contraction and profit decline, raising concerns about execution and near-term profitability amidst this ambitious expansion phase.
Latest issuer-disclosed distribution across 3 reported categories.
Targeting 8% global market share in OHT segment, with a strategic goal of 10% through modular, phased investments.
Expanding capacity to capitalize on synergies and become a preferred supplier for Tire & Non-Tire segments.
Planned modular entry into Premium Passenger Car Radial Tires and Commercial Vehicles Radial Tires, focusing on the Indian replacement market.
Additional capex of Rs. 2,000 Cr approved for capacity expansion & infrastructure development across both OHT & On-highway tyre categories. OHT capacity to increase to 425,000 MTPA.
Phase 1 capacity increased to 265,000 MTPA in 2026. Phase 2 from 265,000 MTPA to 360,000 MTPA will be onstream in Q1FY27.
On-going capex program includes Rs. 1,300 Cr (Aug 2024) for OHT Tyres and Rs. 3,500 Cr (May 2025) for On-Highway Tyres, Rubber Tracks, Carbon Black and Power Plant.
Good recovery in H2 over H1 in Europe, improving traction in Americas, and sustained momentum in India for OHT business.
Early response from market for On-Highway Commercial Vehicles Tyres has been encouraging.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
YoY is crucial for assessing overall annual performance and market trends in a cyclical industry like auto ancillaries. QoQ provides insights into sequential momentum, especially with new product launches and capacity ramp-ups.
FY26: 3,17,356 MT (+1% YoY); Q4FY26: 85,820 MT (+5% YoY).
FY26: Rs. 10,656 Cr (Flat YoY); Q4FY26: Rs. 2,894 Cr (+2% YoY).
FY26: 22.7% (-252 bps YoY); Q4FY26: 22.9% (-187 bps YoY).
FY26: Rs. 1,222 Cr (-25% YoY); Q4FY26: Rs. 295 Cr (-19% YoY).
Targeting 2.2x revenue growth to ~Rs. 23,000 Cr by FY30, implying a 5-year CAGR of ~17%.
Overall Capex till FY29 is projected at Rs. 6,800 Cr.
Expect blended margins post full commercialization to be in the range of 23-25%, allowing absolute EBITDA to grow significantly.
Do not anticipate a significant decline in ROCE as full potential is achieved, backed by enhanced revenue and operational strengths.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| OHT Sales Volume | 3,17,356 MT (FY26) | Sustained volume growth and progress towards 425,000 MTPA capacity utilization. |
| On-Highway Business Ramp-up | CV Radial pilot launched Q4FY26, PCR pilot Q3FY27. | Market share gains and revenue contribution towards 20% by FY30. |
| EBITDA Margin | 22.7% (FY26) | Stabilization and recovery towards management's 23-25% target. |
| Carbon Black Capacity Utilization | Phase 1 at 265,000 MTPA (2026) | Successful commissioning of Phase 2 (360,000 MTPA in Q1FY27) and utilization rates. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Capex for the current fiscal year is envisaged to be close to INR2,000 crores to INR2,200 crores.
"we envisage the year-end to be close to- INR 2,000 crores to INR2,200 crores"
Company aims to achieve INR23,000 crores in revenue by 2030.
"achieving INR23,000 crores in revenue by 2030"
Outcome check: Revenue YoY averaged 6.7% across 2 later quarter(s).
Raw material cost is expected to be similar for the next quarter due to EUDR.
"we expect a similar cost for the next quarter"
TBR and PCR pilot production will start in the second half of the next fiscal year.
"will start somewhere in the second half of the next fiscal"
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Management has 100% delivered/partly-delivered outcomes on 1 checked claims. It ranks around the 69th percentile of the scored universe and 47th percentile within Auto. Main check: financial discipline is weak at 50/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · Auto: 47th pctile, median 74 · Large: 46th pctile, median 73
114 documents have extracted text, but claim history is not strong enough yet.
1/4 claims checked · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse